Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 791Diabetes Management and ResearchPancreatic function and diabetesDiabetes Treatment and Management

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; 10 of the 22 sources its claims cite were checked for support.

The UVA/PADOVA Type 1 Diabetes Simulator: New Features

Open access
Man, Chiara Dalla, Micheletto, Francesco, Lv, Dayu, Breton, Marc, Kovatchev, Boris, Cobelli, Claudio·2014·Journal of Diabetes Science and Technology

Abstract

Recent studies have provided new insights into nonlinearities of insulin action in the hypoglycemic range and into glucagon kinetics as it relates to response to hypoglycemia. Based on these data, we developed a new version of the UVA/PADOVA Type 1 Diabetes Simulator, which was submitted to FDA in 2013 (S2013). The model of glucose kinetics in hypoglycemia has been improved, implementing the notion that insulin-dependent utilization increases nonlinearly when glucose decreases below a certain threshold. In addition, glucagon kinetics and secretion and action models have been incorporated into the simulator: glucagon kinetics is a single compartment; glucagon secretion is controlled by plasma insulin, plasma glucose below a certain threshold, and glucose rate of change; and plasma glucagon stimulates with some delay endogenous glucose production. A refined statistical strategy for virtual patient generation has been adopted as well. Finally, new rules for determining insulin to carbs ratio (CR) and correction factor (CF) of the virtual patients have been implemented to better comply with clinical definitions. S2013 shows a better performance in describing hypoglycemic events. In addition, the new virtual subjects span well the real type 1 diabetes mellitus population as demonstrated by good agreement between real and simulated distribution of patient-specific parameters, such as CR and CF. S2013 provides a more reliable framework for in silico trials, for testing glucose sensors and insulin augmented pump prediction methods, and for closed-loop single/dual hormone controller design, testing, and validation.

Overview

CoChat Summary

TL;DR

The paper presents S2013, a new version of the UVA/PADOVA Type 1 Diabetes Simulator, adding hypoglycemia-aware glucose utilization, glucagon secretion/action, updated joint parameter distributions, and stricter virtual-subject generation. The authors argue that S2013 better describes hypoglycemic events and better matches real CR and CF distributions, while remaining FDA-submitted for preclinical in silico use.

Key findings

  • The original S2008 simulator included a population of 300 in silico subjects: 100 adults, 100 adolescents, and 100 children; the paper says S2008 had been used by 32 research groups and reported in 63 peer-reviewed publications.
  • S2013 adds a hypoglycemia model with a threshold set at 60 mg/dl and incorporates glucagon kinetics/secretion/action, including a 1-compartment glucagon kinetics model and a 2-compartment subcutaneous glucagon transit model.
  • The new simulator was assessed on 32 T1DM subjects in an unpublished clamp dataset and on 13 data sets from 11 adults with T1DM in a bihormonal closed-loop clinical trial; the paper states the model fits glucose data well before the threshold and underestimates data afterward as expected.
  • In simulation results for 100 adults, 100 adolescents, and 100 children, the paper reports that the distributions of CR and CF “well reproduce” real patients, and that children had higher CFs than adolescents and adults; the table reports mean weight, insulin needs, CHO ratio, and fasting plasma glucose for each group.

Methods

  • The paper is a simulator-development paper comparing S2013 to S2008, describing changes to the glucose-insulin model, counterregulation, parameter distributions, and virtual patient generation.
  • It uses simulation and model identification/assessment on two empirical datasets: 32 T1DM subjects undergoing hyperinsulinemic euglycemic and hypoglycemic clamps, and 11 adults with T1DM (13 data sets) from a 27-hour bihormonal closed-loop study with 3 carbohydrate-rich meals.
  • Main analyses include fitting the hypoglycemia model, simulating 50 g CHO meal tests for CR estimation, using the 1700 rule for CF, and filtering virtual subjects by CR thresholds, steady-state glucose > 300 mg/dl, and Mahalanobis distance below the 95% percentile.

Limitations

  • The authors explicitly state that the subcutaneous glucagon model “suffers some important limitations,” because it was hard to isolate insulin’s effect on glucagon response since insulin is constantly changing, and glucagon is given repeatedly in the study.
  • They note that both S2008 and S2013 were validated and accepted by FDA for a single meal scenario only; multiple-meal scenarios can be simulated, but results would not be realistic because the simulator does not include time-varying parameters.
  • Evident from the text: the paper repeatedly presents validation and comparison results, but it does not report formal performance metrics such as error estimates, p-values, or confidence intervals for the simulator comparisons.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/1932296813514502

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

6 Valid · 2 Not valid · 5 Not checked · 24 Own results and interpretations

13 more claims

Create a free account to see all 37 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 5

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 25 references

Research works printed but not linked: 4

  1. Bergman RN, 1979, Am J Physiol, 236, E667
  2. Lorenzi M, 1984, West J Med, 141, 467
  3. Walsh J, Pumping Insulin. Everything You Need for Success with an Insulin Pump, 2000, 105
  4. Davidson PC, 2003, Diabetes Technol Ther, 5, 237

Cited by

See all 791

Metadata

Authors
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C.
Affiliations
  • University of Padua (IT)
  • University of Virginia (US)
Venue
Journal of Diabetes Science and Technology
Published
2014-01
Volume
8
Issue
1
Pages
26-34
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2129995532
Cited by
791
References
25
Citations by year
2026: 49 · 2025: 85 · 2024: 76 · 2023: 89 · 2022: 69 · 2021: 76 · 2020: 91 · 2019: 77 · 2018: 66 · 2017: 47 · 2016: 30 · 2015: 23 · 2014: 10
FWCI
29.50
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, hypoglycemia, glucose kinetics, virtual patients, correction factors, in silico clinical trials, artificial pancreas, glucose sensor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The UVA/PADOVA Type 1 Diabetes Simulator: New Features. https://app.cochat.ai/papers/10.1177/1932296813514502
The paper
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014). The UVA/PADOVA Type 1 Diabetes Simulator: New Features. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296813514502

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.